Glandular function in sjögren syndrome: Assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling - Initial experience

Radiology

Volumn 246, Issue 3, 2008, Pages 845-853

  Roberts, Caleb ^a   Parker, Geoff J M ^a   Rose, Chris J ^a   Watson, Yvonne ^a   O'Connor, James P ^a   Stivaros, Stavros M ^a   Jackson, Alan ^a   Rushton, Vivian E ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KINETICS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SJOEGREN SYNDROME; CASE CONTROL STUDY; DISCRIMINANT ANALYSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; ROC CURVE; THREE DIMENSIONAL IMAGING;

CONTRAST MEDIUM;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRAST MEDIA; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAROTID GLAND; PROSPECTIVE STUDIES; ROC CURVE; SJOGREN'S SYNDROME;

EID: 40949125161     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2463070298     Document Type: Article

References (34)

1. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-229.
2. Lee M, Rutka JA, Slomovic AR, McComb J, Bailey DJ, Bookman AA. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjogren's syndrome. J Rheumatol 1998;25:247-253.
3. Ohbayashi N, Yamada I, Yoshino N, Sasaki T. Sjogren syndrome: comparison of assessments with MR sialography and conventional sialography. Radiology 1998;209:683-688.
4. Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H. Sjogren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med 2000;41:257-262.
5. Markusse HM, Pillay M, Breedveld FC. The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjogren's syndrome. Br J Rheumatol 1993;32:231-235.
6. Lindvall AM, Jonsson R. The salivary gland component of Sjogren's syndrome: an evaluation of diagnostic methods. Oral Surg Oral Med Oral Pathol 1986;62:32-42.
7. Vitali C. Classification criteria for Sjogren's syndrome. Ann Rheum Dis 2003;62:94-95.
8. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.
9. Spath M, Kruger K, Dresel S, Grevers G, Vogl T, Schattenkirchner M. Magnetic resonance imaging of the parotid gland in patients with Sjogren's syndrome. J Rheumatol 1991;18:1372-1378.
10. Chikui T, Okamura K, Tokumori K, et al. Quantitative analyses of sonographic images of the parotid gland in patients with Sjogren's syndrome. Ultrasound Med Biol 2006;32:617-622.
11. Ariji Y, Ohki M, Eguchi K, et al. Texture analysis of sonographic features of the parotid gland in Sjogren's syndrome. AJR Am J Roentgenol 1996;166:935-941.
12. Makula E, Pokorny G, Kiss M, et al. The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjogren's syndrome. Rheumatology (Oxford) 2000;39:97-104.
13. Morimoto Y, Habu M, Tomoyose T, et al. Dynamic magnetic resonance sialography as a new diagnostic technique for patients with Sjogren's syndrome. Oral Dis 2006;12:408-414.
14. Niemela RK, Takalo R, Paakko E, et al. Ultrasonography of salivary glands in primary Sjogren's syndrome: a comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology (Oxford) 2004;43:875-879.
15. Niemela RK, Paakko E, Suramo I, Takalo R, Hakala M. Magnetic resonance imaging and magnetic resonance sialography of parotid glands in primary Sjogren's syndrome. Arthritis Rheum 2001;45:512-518.
16. El Miedany YM, Ahmed I, Mourad HG, et al. Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjogren's syndrome? Joint Bone Spine 2004;71:29-38.
17. Izumi M, Eguchi K, Ohki M, et al. MR imaging of the parotid gland in Sjogren's syndrome: a proposal for new diagnostic criteria. AJR Am J Roentgenol 1996;166:1483-1487.
18. Thoeny HC, De Keyzer F, Claus FG, Sunaert S, Hermans R. Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 2005;235:629-634.
19. Jackson A, Buckley D, Parker G, eds. Dynamic contrast-enhanced magnetic resonance imaging in oncology. New York, NY: Springer, 2005.
20. Jayson GC, Parker GJ, Mullamitha S, et al. Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab′, leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 2005;23:973-981.
21. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-195.
22. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
23. Leach MO, Brindle KM, Evelhoch JL, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003;76(spec no 1):S87-S91.
24. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
25. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-357.
26. Plummer D. DispImage: a display and analysis tool for medical images. Rev Neuroradiol 1992;5:489-495.
27. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
28. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000.
29. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
30. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
31. Fox RI. Sjogren's syndrome. Lancet 2005;366:321-331.
32. Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T. Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. AJNR Am J Neuroradiol 1997;18:951-958.
33. Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006;23:554 -563.
34. Roberts C, Buckley DL, Parker GJ. Comparison of errors associated with single- and multiple-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. Magn Reson Med 2006;56:611-619.